fosinopril has been researched along with captopril in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (7.69) | 18.7374 |
1990's | 23 (44.23) | 18.2507 |
2000's | 15 (28.85) | 29.6817 |
2010's | 9 (17.31) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M | 1 |
Cordis, GA; Das, DK; Engelman, RM; Liu, X; Rousou, JA | 1 |
Cushman, DW; Dzwonczyk, S; Fung, W; Grover, GJ; Sleph, PG; Tobias, D; Wang, P | 1 |
Aber, GM; Harding, P; Stonier, C | 2 |
Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
Abboa-Offei, B; Seymour, AA; Swerdel, JN | 1 |
Cushman, DW; DeForrest, JM; Harvey, C; Petrillo, EW; Powell, JR; Rubin, B; Scalese, B; Waldron, TL | 1 |
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
Mackaness, GB | 1 |
Cushman, DW; Ondetti, MA; Petrillo, EW; Powell, JR | 1 |
Aberg, G; Andersson, RG; Jacobsson, LS; Karlberg, BE; Olsson, AG; Persson, K | 1 |
Baker, JR; Bigby, TD; Kylstra, TA | 1 |
Karlberg, BE; Olsson, AG; Wuttge, DM; Ziedén, B | 1 |
Aberg, G; Beyer, S; Kowala, MC; Recce, R | 1 |
Ambrosioni, E; Bacchelli, S; Borghi, C | 1 |
Aberg, G; Grove, RI; Kowala, MC | 1 |
Bastani, B; Redington, J | 1 |
Andersson, RG; Jacobsson, L; Persson, K | 1 |
Hess, E; Sperschneider, H; Stein, G | 1 |
Anderssson, PE; Berglund, L; Haenni, A; Lind, L; Lithell, H; Reneland, R | 1 |
Szucs, TD | 1 |
Benzie, IF; Tomlinson, B | 1 |
Altmann, C; Horstmann, E; Josephs, W; Konermann, M; Laschewski, F; Odenthal, HJ; Sanner, B | 1 |
Akarawut, W; Lin, CJ; Smith, DE | 1 |
Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
Gallardo, J; García-Robles, R; Rodríguez-García, JL; Serrano, M; Villa, E | 1 |
Altmann, C; Konermann, M; Laschewski, F; Odenthal, HJ; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
Altmann, C; Konermann, M; Laschewski, F; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
Ayan, F; Eryonucu, B; Keser, N; Koldas, L; Sirmaci, A | 1 |
Cozzani, E; Drosera, M; Milesi, G; Parodi, A; Rebora, A | 1 |
Bicket, DP | 1 |
Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
Karkishchenko, NN; Makliakov, IuS; Sarbilina, IV | 1 |
Gardiner, G; Guindi, M; Joshi, S; Shiota, K; Wanless, IR; Wong, FS; Yeung, E | 1 |
Pfützner, W; Przybilla, B; Ruëff, F | 1 |
Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
Chen, JL; Gao, RL; Pei, WD; Sun, YH; Yang, YJ; Zhang, YH; Zhao, JL | 1 |
Medvedev, IN; Simonenko, VB; Tolmachev, VV | 1 |
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
Citraro, R; Gallelli, L; Gareri, P; Gratteri, S; Paola, ED; Rispoli, V; Russo, E; Sarro, GD; Siniscalchi, A; Tripepi, G | 1 |
Fish, BL; Gao, F; Jacobs, ER; Kma, L; Medhora, M; Moulder, JE | 1 |
Cohen, EP; Fish, BL; Moulder, JE | 1 |
Abu Hasan, Z'; Acharya, KR; Cozier, GE; Isaac, RE; Ismail, NM; Othman, H; Williams, H | 1 |
Mahrouse, MA | 1 |
Karahan, F; Turkoglu, V | 1 |
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
7 review(s) available for fosinopril and captopril
Article | Year |
---|---|
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction | 1994 |
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for fosinopril and captopril
Article | Year |
---|---|
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Captopril; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Insulin; Lisinopril; Magnesium; Male; Middle Aged | 1997 |
Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Organ Size; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 1998 |
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Case-Control Studies; Enalapril; Epoprostenol; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prostaglandins; Ramipril | 1999 |
[Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged | 2001 |
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
38 other study(ies) available for fosinopril and captopril
Article | Year |
---|---|
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents | 1992 |
Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Creatine Kinase; Fosinopril; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Reperfusion Injury; Myocardium; Phospholipids; Proline; Rats; Rats, Inbred Strains; Ventricular Function, Left | 1992 |
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Drug Stability; Enalaprilat; Fosinopril; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Prodrugs; Proline; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Culture Techniques; Dinoprostone; Eicosanoids; Enalapril; Fosinopril; Hypertension; Kidney Glomerulus; Male; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2 | 1991 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fosinopril; Hypertension; Male; Neprilysin; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
Topics: Acute Kidney Injury; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dogs; Fosinopril; Heart Rate; Injections, Intravenous; Macaca fascicularis; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Time Factors | 1989 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
The future of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding Sites; Captopril; Diuretics; Fosinopril; Humans; Intestinal Absorption; Kinetics; Organophosphorus Compounds; Renin; Snake Venoms; Zinc | 1985 |
Angiotensin-converting enzyme inhibitors: accomplishments and challenges.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical Phenomena; Chemistry; Enalapril; Fosinopril; Humans; Proline | 1987 |
Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
Topics: Aldosterone; Animals; Arteriosclerosis; Blood Pressure; Captopril; Diet, Atherogenic; Female; Fosinopril; Hypercholesterolemia; Lipoproteins; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
Topics: Aminopeptidases; Captopril; Cell Line; Cell-Free System; Epithelium; Epoxide Hydrolases; Fosinopril; Humans; Kinetics; Leucine; Leukotriene B4; Metalloendopeptidases; Neutrophils; Protease Inhibitors | 1995 |
Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Copper; Ethanol; Fosinopril; Humans; In Vitro Techniques; Isoquinolines; Lipoproteins, LDL; Oxidation-Reduction; Quinapril; Tetrahydroisoquinolines | 1995 |
Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Captopril; Cell Count; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Image Processing, Computer-Assisted; Macrophages; Male | 1995 |
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Cricetinae; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Lipids; Macrophages; Male | 1994 |
Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Captopril; Enalapril; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Retrospective Studies; Weight Gain | 1994 |
Angiotensin converting enzyme inhibitors and atherosclerosis.
Topics: Acetylcholine; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arteriosclerosis; Captopril; Cholesterol; Diet, Atherogenic; Endothelium, Vascular; Female; Fosinopril; Hypercholesterolemia; Muscle Relaxation; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Fosinopril; In Vitro Techniques; Kidney Glomerulus; Male; Prostaglandins; Rats; Rats, Inbred WKY; Reference Values | 1993 |
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enalapril; Erythropoietin; Female; Follow-Up Studies; Fosinopril; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Recombinant Proteins; Renal Dialysis; Retrospective Studies | 1996 |
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Colorimetry; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Fosinopril; Indoles; Isoquinolines; Oxidation-Reduction; Perindopril; Quinapril; Tetrahydroisoquinolines | 1998 |
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Fosinopril as a possible pemphigus-inducing drug.
Topics: Acantholysis; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Cadherins; Captopril; Cell Adhesion Molecules; Desmoglein 3; Female; Fluorescent Antibody Technique, Indirect; Fosinopril; Humans; Middle Aged; Pemphigus | 2002 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
[Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Fosinopril; Glucose; Heart Failure; Hemodynamics; Humans; Immunologic Factors; Male; Oligopeptides; Ramipril; Time Factors | 2003 |
Ramipril-associated hepatotoxicity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury, Chronic; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Enalapril; Fosinopril; Humans; Jaundice; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ramipril | 2003 |
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines | 2004 |
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins | 2006 |
Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Electrocardiography; Enalapril; Female; Fosinopril; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Research Design; Stroke Volume; Time Factors; Treatment Outcome | 2007 |
[Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Hypertension; Male; Metabolic Syndrome; Platelet Activating Factor | 2007 |
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Captopril; Drug Synergism; Enalapril; Female; Fosinopril; Male; Mice; Motor Activity; Seizures | 2012 |
Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Enalapril; Female; Fibrosis; Fosinopril; Gene Expression Regulation; Lung; Pulmonary Fibrosis; Radiation Pneumonitis; Rats; Renin-Angiotensin System; Thorax | 2012 |
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation | 2014 |
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.
Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Captopril; Disease Vectors; Fosinopril; Humans; Insecticide Resistance; Insecticides; Larva; Mosquito Vectors; Peptidyl-Dipeptidase A | 2017 |
Simultaneous ultraperformance liquid chromatography/tandem mass spectrometry determination of four antihypertensive drugs in human plasma using hydrophilic-lipophilic balanced reversed-phase sorbents sample preparation protocol.
Topics: Antihypertensive Agents; Benzazepines; Captopril; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Fosinopril; Humans; Hydrochlorothiazide; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Linear Models; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry | 2018 |
Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Chromatography, Affinity; Fosinopril; Hydrogen-Ion Concentration; Kinetics; Lisinopril; Lung; Peptidyl-Dipeptidase A; Protein Stability; Temperature; Triamterene | 2021 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |